BC Centre for Excellence in HIV/AIDS

What BC Centre for Excellence in HIV/AIDS does

The BC Centre for Excellence in HIV/AIDS (BC-CfE) is a non-profit provincial research, treatment, and education facility headquartered at St. Paul's Hospital in Vancouver, British Columbia, founded in 1992. It operates as the centralized HIV/AIDS program for the BC Ministry of Health, serving all health authorities and citizens of the province. Its core offerings include the provincial Drug Treatment Program (distributing free antiretroviral therapy, PrEP, and PEP to qualifying BC residents), the Treatment as Prevention (TasP®) public health strategy, the Hope to Health Research & Innovation Centre (H2H) primary care clinic in Vancouver's Downtown Eastside, and the Urban Health Acute Care Unit at St. Paul's Hospital. The organization also operates a laboratory program (HIV resistance genotyping, low-level viremia analysis), multiple epidemiology and population health research cohorts, the STOP HIV/AIDS® provincial initiative, and accredited education/training programs including the Canadian Treatment as Prevention Summit.

Underlying technology and methodology center on the proprietary TasP® approach (widespread HIV testing plus immediate initiation of highly active antiretroviral therapy), supported by longitudinal treatment registries, viral genomic and phylogenetic analysis, and emerging AI/machine learning tools for transmission pattern mapping (Genome BC-funded Genesolve project announced December 2025). The organization is extending TasP® methodology beyond HIV to viral hepatitis and addiction through its Targeted Disease Elimination® framework and operates harm reduction services including a supervised consumption site at H2H.

BC-CfE is funded through BC Ministry of Health appropriations (core program funding) and external research grants from CIHR, Genome BC, Genome Canada, the Public Health Agency of Canada, Michael Smith Foundation for Health Research, and other bodies. All HIV treatment medications and PrEP are provided at no cost to qualifying patients through BC's universal healthcare system; BC-CfE does not generate commercial revenue and operates as a public-sector program governed by BC's Freedom of Information and Protection of Privacy Act (FIPPA). The organization's leadership includes Executive Director Dr. Julio Montaner, who pioneered TasP® and co-developed the HAART antiretroviral cocktail that became the global standard of HIV care.

Name

BC Centre for Excellence in HIV/AIDS

Legal name

British Columbia Centre for Excellence in HIV/AIDS

Website

https://bccfe.ca

Company type

Private

Founded year

1992

Operating status

Operating

Headcount range

251–500 employees

Short description

The BC Centre for Excellence in HIV/AIDS is a provincial research, treatment, and education facility in Vancouver that operates BC's centralized HIV/AIDS program for the Ministry of Health, distributing free antiretroviral therapy and PrEP, pioneering the Treatment as Prevention strategy, and running clinical, harm-reduction, and population health research services across British Columbia.

Ownership category

akta.pro rank

Product category

HIV/AIDS Healthcare Services

NAICS

Health Care and Social Assistance (62), Ambulatory Health Care Services (621), Offices of Physicians (62111), All Other Outpatient Care Centers (621498)

SIC

Services-Misc Health & Allied Services, Nec (8090), Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Nursing & Personal Care Facilities (8050)

akta.pro primary industry

HIV/AIDS Medicine (HLAKAGAB)

akta.pro secondary industries

Disease-Specific Global Initiatives (HIV/TB/Malaria/NTDs) (HLAJAOAE), Sexual Health & STI/HIV Prevention Health Departments (HLAJAAAL), Infectious Disease & Immunization Program Funding (HLAJALAH)

Keywords

• HIV/AIDS treatment
• Antiretroviral therapy programs
• HIV prevention programs
• Clinical research services
• Healthcare education training

Headquarters

HQ city

Vancouver

HQ country

Canada

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain

Revenue model

1. Government Healthcare Funding: The BC-CfE is a provincial program funded by the BC Ministry of Health to improve health of British Columbians with HIV through research, treatment programs, and education. HIV treatment medications are provided at no cost to qualifying patients through the provincial healthcare system.
2. Research Grants: Funded by external agencies including Canadian Institutes of Health Research (CIHR), Genome BC, Genome Canada, Public Health Agency of Canada, Michael Smith Foundation for Health Research, and other research funding bodies for specific research projects.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

The BC Centre for Excellence in HIV/AIDS delivers provincially funded HIV/AIDS clinical care, research, and education. Its core services include the Drug Treatment Program providing free antiretroviral therapy to eligible BC residents, the pioneering Treatment as Prevention (TasP) strategy, PrEP and PEP prevention programs, the Hope to Health Centre for integrated primary and HIV care, the Urban Health Acute Care Unit, and a centralized Laboratory Program offering HIV testing and resistance analysis. It also produces nationally and internationally recognized therapeutic guidelines, conducts clinical and epidemiological research, and provides clinical education to healthcare providers across British Columbia.

Product overview

The BC Centre for Excellence in HIV/AIDS (BC-CfE) operates as a provincial research, treatment, and education facility offering a portfolio of clinical programs centered on its pioneering Treatment as Prevention (TasP®) strategy. The core offerings include the TasP® program for HIV treatment, Pre-Exposure Prophylaxis (PrEP), Post-Exposure Prophylaxis (PEP), and the Drug Treatment Programs providing antiretroviral medications. These are complemented by the Hope to Health Research & Innovation Centre (H2H) — an interdisciplinary primary care and supervised consumption facility — and the Urban Health Acute Care Unit at St. Paul's Hospital. The BC-CfE also delivers laboratory services, the STOP HIV/AIDS® provincial initiative, multiple epidemiology and population health research programs (CANOC, Momentum, Engage Study, etc.), the Thrive program for older adults with HIV, the RETAIN retention program, comprehensive therapeutic guidelines, and accredited education and training through events like the BC-CfE Update and Canadian Treatment as Prevention Summit. The organization is increasingly applying its TasP® methodology to therapeutic areas beyond HIV/AIDS, including viral hepatitis and addiction, under the Targeted Disease Elimination® framework.

Differentiator

Problem solved

Functional benefit

Brands

• Treatment as Prevention (TasP): A strategy involving widespread offer of HIV testing and immediate offer and use of HAART for people living with HIV.
• STOP HIV/AIDS
• Hope to Health Research & Innovation Centre (H2H)
• Targeted Disease Elimination

Products and services

• Drug Treatment Program Provincially funded, centralized program that provides free antiretroviral therapy to eligible people living with HIV across British Columbia, supported by a longitudinal patient registry and centralized pharmacy and laboratory services.
• Treatment as Prevention (TasP) Program Strategic program and clinical framework that uses expanded antiretroviral therapy coverage to suppress population-level HIV viral load and reduce HIV transmission, developed and championed by the Centre as a public health intervention.
• PrEP and PEP Prevention Programs Clinical programs providing pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) to individuals at high risk of HIV acquisition, integrated with the Centre's broader TasP prevention strategy.
• Hope to Health (H2H) Centre Integrated clinical care centre that combines HIV specialty care, primary care, and wraparound social support services for people living with HIV, particularly those facing intersecting health and social challenges.
• Urban Health Acute Care Unit Specialized acute care unit providing inpatient services for urban populations affected by HIV and related complex health conditions, operated in partnership with St. Paul's Hospital.
• Laboratory Program Centralized laboratory program providing HIV diagnostic testing and HIV resistance genotype analysis that informs treatment selection for patients across BC, and supports research and surveillance activities.
• STOP HIV/AIDS Program Seek and Treat for Optimal Prevention of HIV/AIDS, a provincial partnership program that expands HIV testing, linkage to care, and treatment across BC to reduce HIV incidence at the population level.
• Therapeutic Guidelines Program Program that develops and disseminates evidence-based therapeutic guidelines for HIV antiretroviral therapy, used by clinicians in BC and informing HIV treatment practice nationally and internationally.
• Clinical Education Program Education and training program that delivers continuing medical education, clinical training, and knowledge translation activities to physicians, nurses, pharmacists, and allied health professionals involved in HIV care across BC.

Quantifiable outcome

• 95% decrease in HIV/AIDS-related mortality between 1996 and 2022
• +3 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability4 records

Feature4 records

Partnerships

Eleven partnerships are on record, tiered core, major and minor.

• St. Paul's HospitalcoreStrategic or Co-development PartnerSt. Paul's Hospital is the primary affiliated hospital of the BC-CfE. The organization is housed at St. Paul's Hospital location and operates the Urban Health Acute Care Unit (formerly the 10C HIV/AIDS Ward) within the hospital facility.
• Dr. Peter AIDS FoundationcoreStrategic or Co-development PartnerJoint initiative (The Dr. Peter Study) evaluating the effectiveness of the Dr. Peter Centre model of care for people living with HIV who face multiple barriers to treatment. Funded by CIHR Partnerships in Health System Improvement program.
• Genome British ColumbiamajorStrategic or Co-development PartnerFunding partner for genomic and AI-enabled HIV transmission pattern analysis project announced on World AIDS Day 2025. Led by Dr. Jeffrey Joy to develop new tools for understanding HIV transmission patterns.
• UNAIDSmajorStrategic or Co-development PartnerThe BC-CfE's TasP strategy was adopted by UNAIDS since 2011 and inspired the global 90-90-90 Target (now 95-95-95) to end AIDS as a pandemic by 2030.
• Global Fund to Fight AIDS, Tuberculosis and MalariamajorStrategic or Co-development PartnerInternational partnership that has saved 70 million lives globally. BC-CfE advocates for increased Canadian funding to the Global Fund.
• BC Health AuthoritiescoreStrategic or Co-development PartnerThe BC-CfE serves all health authorities and regions of British Columbia as a provincial program, providing HIV treatment programs, guidelines, and support across the province.
• Canadian Institutes of Health Research (CIHR)majorStrategic or Co-development PartnerPrimary research funding agency providing grants for BC-CfE research initiatives including the Dr. Peter Study and other population health research.
• University of British ColumbiacoreStrategic or Co-development PartnerAcademic partner for research activities. Dr. Jeffrey Joy serves as researcher at both BC-CfE and UBC. Collaborative research in epidemiology and clinical research.
• Stephen Lewis FoundationminorStrategic or Co-development PartnerFoundation established by Stephen Lewis, a former UN Special Envoy for HIV/AIDS in Africa and long-time supporter of BC-CfE, focused on HIV/AIDS work in Africa.
• Genome CanadamajorStrategic or Co-development PartnerCo-funder with Public Health Agency of Canada of previous work that the new Genome BC Genesolve project builds upon for HIV genomic analysis.
• Public Health Agency of CanadamajorStrategic or Co-development PartnerFederal health agency that co-funded previous HIV genomic analysis work with Genome Canada, upon which current research builds.

Scale indicators8 records

Recent moves8 records

Expansion highlights5 records

Direct peers

• Whitman-Walker Health: Washington DC-based community health center specializing in HIV/AIDS care, research, and policy advocacy with interdisciplinary LGBTQ+ care. Highly comparable to BC-CfE's integrated clinical-research-education model serving vulnerable populations.
• Fenway Health: Boston-based federally qualified health center and HIV research center providing integrated clinical care, research, and education for LGBTQ+ and HIV-affected populations. Directly comparable to BC-CfE's H2H/Urban Health model serving marginalized populations with HIV.
• San Francisco AIDS Foundation: Bay Area-based HIV/AIDS services and advocacy organization providing prevention, care, and policy leadership. Comparable to BC-CfE on PrEP/PEP programs, HIV prevention, and population-health outreach to at-risk communities.
• Ontario HIV Treatment Network (OHTN): Canadian provincial HIV/AIDS research and treatment network funded by the Ontario Ministry of Health. Highly comparable to BC-CfE as a sister provincial program providing treatment guidelines, research cohorts, and clinical quality monitoring within a publicly funded healthcare system.
• Canadian AIDS Treatment Information Exchange (CATIE): Canada's national HIV/AIDS knowledge broker providing treatment information, education, and dissemination of evidence-based guidance. Closely comparable to BC-CfE's education/training and therapeutic guidelines functions across Canada.
• CIHR Canadian HIV Trials Network (CTN): CIHR-funded Canadian network headquartered at UBC that designs and conducts HIV clinical trials. Directly comparable to BC-CfE's clinical research portfolio and shares overlapping UBC institutional affiliation and BC scientific ecosystem.

Broad incumbents

• UNAIDS: UN joint program coordinating global HIV/AIDS response that adopted BC-CfE's TasP® framework as the basis for 95-95-95 targets. Comparable as a global policy and programmatic influencer but operates at multilateral scale rather than service delivery.
• AIDS Healthcare Foundation (AHF): Largest global AIDS organization providing HIV/AIDS medical care, treatment, and prevention services across 45+ countries. Operates at much greater scale and global footprint but overlaps with BC-CfE on clinical service delivery, advocacy, and global public health leadership.
• amfAR (Foundation for AIDS Research): Leading global nonprofit HIV/AIDS research foundation funding cure-focused research, treatment, and prevention. Comparable to BC-CfE as a research-advocacy organization but with a national (US) and global funding scope rather than provincial Canadian focus.

Regional players

• Terrence Higgins Trust: UK's leading HIV/AIDS charity providing testing, prevention, treatment support, and policy advocacy. Comparable to BC-CfE on service delivery and national/regional policy influence, but operates in a different geography (UK) and under a non-governmental charity model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/BCCfE
• Facebookfacebook.com/bccfe
• LinkedInlinkedin.com/company/bccfe

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BC Centre for Excellence in HIV/AIDS